EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY-NC 4.0

Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients

Joana Menezes iD, Jenny E Jakobsson iD, Alex Bersellini Farinotti iD, Emerson Krock iD, Matthew A Hunt iD, Nils Simon iD, Sigita Venckute Larsson, Lars Tanum iD, Kim Kultima iD, Eva Kosek iD, Camilla I Svensson iD

European Journal of Pain · 2025

DOI: 10.1002/ejp.70022 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Pain, 2025. Verfasst von Joana Menezes und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden. Hauptthemen laut MEDLINE: Lysophospholipids, Fibromyalgia, Osteoarthritis, Intervertebral Disc Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous work found a decrease in lysophosphatidylcholines (LPCs) in fibromyalgia (FM) serum, prompting the hypothesis that this decrease could be due to increased conversion of LPC to lysophosphatidic acid (LPA) through autotaxin (ATX). LPA has pronociceptive functions, and increased LPA levels could modulate FM pain.

Methods

This study quantified LPA levels in serum and lumbar cerebrospinal fluid (CSF) and serum ATX levels in FM patients, comparing with healthy controls (HCs), osteoarthritis (OA), degenerative disc disease (DDD) and lumbar disc herniation (LDH) patients.

Results

We found increased serum LPA levels in FM and OA patients, with no changes in FM lumbar CSF. Unexpectedly, a positive correlation between serum LPA and conditioned pain modulation was observed in FM patients, while LPA levels were correlated with pain intensity and Knee Injury and Osteoarthritis Outcome Scores in OA. Serum ATX levels in FM patients were comparable to those in HC but correlated significantly with FM LPA levels (in one cohort), as well as with pain duration and the maximal weekly pain intensity.

Conclusions

This study suggests that increased LPA levels play distinct roles in FM and OA patients. In FM, LPA levels were linked to less impaired inhibitory pain pathways, while LPA levels in OA correlated with pain intensity and knee‐related impairment. ATX levels in FM serum are associated with pain intensity and duration. These findings underscore the complex role of LPA and ATX in FM pathophysiology. Future studies are essential to clarify LPA's specific roles and to develop therapies. Significance Statement This study provides novel insights into the role of LPA in FM and other chronic pain conditions. Although ATX levels were unchanged in FM, a positive correlation between serum ATX and LPA supports the role of ATX in LPA conversion. These findings suggest complex lipid dysregulation in FM, with LPA potentially modulating pain pathways. Further research is needed to clarify LPA's role and its potential as a biomarker or therapeutic target.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysophospholipidsFibromyalgiaOsteoarthritisIntervertebral Disc DegenerationIntervertebral Disc DisplacementHumansFemaleMiddle AgedAdultPhosphoric Diester HydrolasesPain MeasurementLysophospholipase D

Substanzen

LysophospholipidsPhosphoric Diester HydrolasesLysophospholipase Dlysophosphatidic acid

Autor:innen und Institutionen

  • Department of Physiology and Pharmacology, Center for Molecular Medicine, Karolinska Institutet, Solna, Sweden.
  • Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
  • Clinical Pain Research, Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.
  • Faculty of Dental Medicine and Oral Health Sciences, Alan Edwards Centre for Research on Pain, McGill University, Montreal, Canada.
  • Department of R&D in Mental Health, Akershus University Hospital, Lørenskog, Norway.
  • Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.

ORCID-Profile: Joana Menezes, Jenny E Jakobsson, Alex Bersellini Farinotti, Emerson Krock, Matthew A Hunt, Nils Simon, Lars Tanum, Kim Kultima, Eva Kosek, Camilla I Svensson

Zitieren

APA

Menezes, J., Jakobsson, J. E., Bersellini Farinotti, A., Krock, E., Hunt, M. A., Simon, N., Venckute Larsson, S., Tanum, L., Kultima, K., Kosek, E., & Svensson, C. I. (2025). Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients. European Journal of Pain. https://doi.org/10.1002/ejp.70022

Vancouver

Menezes J, Jakobsson JE, Bersellini Farinotti A, Krock E, Hunt MA, Simon N, et al. Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients. European Journal of Pain. 2025. doi:10.1002/ejp.70022

BibTeX
@article{Menezes2025,
  author = {Menezes, Joana and Jakobsson, Jenny E and Bersellini Farinotti, Alex and Krock, Emerson and Hunt, Matthew A and Simon, Nils and Venckute Larsson, Sigita and Tanum, Lars and Kultima, Kim and Kosek, Eva and Svensson, Camilla I},
  title = {Comparative Analysis of Lysophosphatidic Acid Levels in Fibromyalgia and Other Painful Conditions in Female Patients},
  journal = {European Journal of Pain},
  year = {2025},
  doi = {10.1002/ejp.70022}
}
Kostenlos starten →